Abstract:Competitive bacteria-bacteriophage interactions have resulted in the evolution of a plethora of bacterial defense systems preventing phage propagation. In recent years, computational and bioinformatic approaches have underpinned the discovery of numerous novel bacterial defense systems. Anti-phage systems are frequently encoded together in genomic loci termed defense islands. Here we report the identification and characterisation of a novel anti-phage system, that we have termed Shield, which forms part of the Pseudomonas defensive arsenal. The Shield system comprises the core component ShdA, a membrane-bound protein harboring an RmuC domain. Heterologous production of ShdA alone is sufficient to mediate bacterial immunity against several phages. We demonstrate that Shield and ShdA confer population-level immunity and that they can also decrease transformation efficiency. We further show that ShdA homologues can degrade DNA in vitro and, when expressed in a heterologous host, can alter the organisation of the host chromosomal DNA. Use of comparative genomic approaches identified how Shield can be divided into four subtypes, three of which contain additional components that in some cases can negatively affect the activity of ShdA and/or provide additional lines of phage defense. Collectively, our results identify a new player within the Pseudomonas bacterial immunity arsenal that displays a novel mechanism of protection, and reveals a role for RmuC domains in phage defense. The evolutionary pressure exerted by bacteriophages has driven bacteria to acquire numerous defense systems. Recent studies have highlighted the extraordinary diversity of these systems, uncovering exciting links between bacterial and eukaryotic immunity. Here we describe a novel anti-phage system, named Shield, found within Pseudomonas species. We identify several Shield subtypes, all harboring the same core component, and describe its mode of action. The growing instance of multidrug-resistant bacterial infections urgently requires the development of alternative treatments. Phage therapy is a particularly pertinent approach to treat multi-drug resistant Pseudomonas aeruginosa strains causing severe lung infection in cystic fibrosis patients. A detailed understanding of bacterial immunity and phage counter-strategies is an essential step to underpin the rational design of phage therapy to fight disease.

Discovery of antiphage systems in the lactococcal plasmidome

Functional and practical insights into three lactococcal antiphage systems

Phage defence loci of Streptococcus thermophilus— tip of the anti-phage iceberg?

A functional selection reveals previously undetected anti-phage defence systems in the E. coli pangenome

A family of lanthipeptides with anti-phage function

Systematic discovery of antiphage defense systems in the microbial pangenome

The novel anti-phage system Shield co-opts an RmuC domain to mediate phage defense across Pseudomonas species

Structure-guided discovery of anti-CRISPR and anti-phage defense proteins

The highly diverse antiphage defence systems of bacteria

Systematic Discovery of Phage Genes that Inactivate Bacterial Immune Systems

Bacterial homologs of innate eukaryotic antiviral defenses with anti-phage activity highlight shared evolutionary roots of viral defenses

Diverse and abundant phages exploit conjugative plasmids

Strengthening Phage Resistance of Streptococcus thermophilus by Leveraging Complementary Defense Systems

Bacterial defense systems exhibit synergistic anti-phage activity

Core defense hotspots within Pseudomonas aeruginosa are a consistent and rich source of anti-phage defense systems

Accumulation of defense systems in phage-resistant strains of Pseudomonas aeruginosa

Sedentary chromosomal integrons as biobanks of bacterial anti-phage defence systems

Comprehensive Analysis of Antiphage Defense Mechanisms: Serovar-Specific Patterns

Innate antiviral systems are major defensome components that drive prophage distribution in Acinetobacter baumannii

DNA glycosylases provide antiviral defence in prokaryotes

Decoupling the molecular versatility of aminoglycosides via drug or target modification enables community-wide antiphage defense